The team reviewed 25 past trials that included over 8000 participants, and say those people who were taking GLP-1s also reported moderate reductions in the severity of their binge eating when compared with people not on the meds, or on other weight-loss medications
This section discusses the key market trends influencing the various segments of the GLP-1 Analogues market as identified by our research experts
Related Product Customer Reviews Reviews There are no reviews yet
Venkatesh A, Ma S, Le YZ, Hall MN, Ruegg MA, Punzo C
References Cosmo Korea
Publication Details Paper Title: Short- and long-term effects of semaglutide 2.4 mg on energy intake, appetite, and food reward: a 60-week, double-blind randomized controlled trial | Authors: Jena S